Literature DB >> 3691652

Depression by flupirtine, a novel analgesic agent, of motor and sensory responses of the nociceptive system in the rat spinal cord.

K H Carlsson1, I Jurna.   

Abstract

The analgesic agent, flupirtine, was tested on motor and sensory responses of the nociceptive system in rats. The motor response was determined in the tail-flick test with radiant heat. The sensory response was determined as activity evoked in ascending axons by electrical stimulation of nociceptive afferents in the sural nerve. The tail-flick latency was dose dependently increased by flupirtine administered by intraperitoneal (i.p.) injection (ED50 7.8 mg/kg), intrathecal (i.t.) injection (ED50 14.8 micrograms/rat) or bilateral microinjection into the periaqueductal grey (PAG; ED50 2.6 micrograms/rat). Naloxone reduced the effect of an i.p. injection of flupirtine but was ineffective against an i.t. injection of the drug. The activity in ascending axons responding to afferent C fibre stimulation was depressed by flupirtine administered by intravenous (i.v.) injection (7 mg/kg) under urethane anaesthesia with an intact spinal cord and brain, and by i.t. injection (14 micrograms/rat) to decerebrated spinal rats. Naloxone did not abolish the depressant effect of i.t. injections of flupirtine. Microinjection of flupirtine (1.7 micrograms/rat) made in the PAG did not reduce, but increased the spontaneous and C fibre-evoked activity in ascending axons. The results indicate that flupirtine selectively depresses responses of the nociceptive system by a spinal (motor and sensory responses) and a supraspinal (motor response) action in which opiate-like mechanisms play no or a minor role.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3691652     DOI: 10.1016/0014-2999(87)90738-2

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  13 in total

1.  Possible involvement of noradrenergic descending pain-modulating pathways in the mode of antinociceptive action of flupirtine, a novel non-opioid analgesic.

Authors:  B Nickel; J Engel; I Szelenyi
Journal:  Agents Actions       Date:  1988-02

2.  Mode of antinociceptive action of flupirtine in the rat.

Authors:  I Szelenyi; B Nickel; H O Borbe; K Brune
Journal:  Br J Pharmacol       Date:  1989-07       Impact factor: 8.739

Review 3.  Flupirtine, a re-discovered drug, revisited.

Authors:  Istvan Szelenyi
Journal:  Inflamm Res       Date:  2013-01-16       Impact factor: 4.575

Review 4.  Flupirtine. A review of its pharmacological properties, and therapeutic efficacy in pain states.

Authors:  H A Friedel; A Fitton
Journal:  Drugs       Date:  1993-04       Impact factor: 9.546

5.  Antiparkinsonian effect of flupirtine in monoamine-depleted rats.

Authors:  M Schwarz; M Nolden-Koch; J Purr; G Pergande; F Block
Journal:  J Neural Transm (Vienna)       Date:  1996       Impact factor: 3.575

6.  Dose-related analgesic effects of flupirtine.

Authors:  T Hummel; T Friedmann; E Pauli; G Niebch; H O Borbe; G Kobal
Journal:  Br J Clin Pharmacol       Date:  1991-07       Impact factor: 4.335

7.  Influence of flupirtine, a novel nonopioid analgesic agent on somatosensory evoked potentials in rats.

Authors:  L Nagymajtenyi; B Nickel; I Desi; I Szelenyi
Journal:  Experientia       Date:  1992-10-15

8.  Opiate System Mediate the Antinociceptive Effects of Coriandrum sativum in Mice.

Authors:  Abbas Ali Taherian; Abbas Ali Vafaei; Javad Ameri
Journal:  Iran J Pharm Res       Date:  2012       Impact factor: 1.696

9.  Evaluation of Analgesic Activity of Papaver libanoticum Extract in Mice: Involvement of Opioids Receptors.

Authors:  Mohamad Ali Hijazi; Ahmed El-Mallah; Maha Aboul-Ela; Abdalla Ellakany
Journal:  Evid Based Complement Alternat Med       Date:  2017-02-08       Impact factor: 2.629

10.  Phytochemical, analgesic, antibacterial, and cytotoxic effects of Alpinia nigra (Gaertn.) Burtt leaf extract.

Authors:  A M Abu Ahmed; Farjana Sharmen; Adnan Mannan; Md Atiar Rahman
Journal:  J Tradit Complement Med       Date:  2015-01-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.